The Global Glaucoma Therapeutics Market is witnessing steady expansion, driven by rising disease prevalence and continuous innovation in ophthalmology. According to The Insight Partners, Glaucoma Therapeutics Market is projected to grow from US$ 6.24 billion in 2022 to US$ 8.02 billion by 2031, registering a CAGR of 3.2% during 2021–2031. A major highlight of this growth trajectory lies...